Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Springer Seminars in Immunopathology|September 16, 2006
Recombinant vesicular stomatitis virus as an HIV-1 vaccine vectorDavid K Clarke, David Cooper, Michael A Egan, et al.Journal of Virological Methods|March 27, 2007
Quantitative multiplex assay for simultaneous detection of the Indiana serotype of vesicular stomatitis virus and HIV gagJohn W Coleman, Eleanor Ogin-Wilson, J Erik Johnson, et al.Vaccine|July 11, 2016
Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessmentDavid K Clarke, R Michael Hendry, Vidisha Singh, et al.Journal of Virology|December 8, 2006
Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocationsDavid K Clarke, Farooq Nasar, Margaret Lee, et al.Virology|November 14, 2006
Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primatesJ Erik Johnson, Farooq Nasar, John W Coleman, et al.Journal of Virology|February 3, 2017
Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus ChallengeFarooq Nasar, Demetrius Matassov, Robert L Seymour, et al.Vaccine|May 12, 2009
In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculationJ Erik Johnson, John W Coleman, Narender K Kalyan, et al.Nature|April 9, 2015
Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virusChad E Mire, Demetrius Matassov, Joan B Geisbert, et al.Journal of Virology|October 19, 2007
Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in miceDavid Cooper, Kevin J Wright, Priscilla C Calderon, et al.The Journal of Infectious Diseases|June 26, 2015
Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola VirusDemetrius Matassov, Andrea Marzi, Terri Latham, et al.Pageof 3